欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0879/001
药品名称Paclitaxel Kabi 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung
活性成分
    • Paclitaxel 6.0 mg/ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Austria GmbH Hafnerstraße 36 8055 Graz Österreich RMS transfer from UK/H/1335/001
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 08828/0186 - 0032
    • Germany (DE)
      Paclitaxel Kabi 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
      Paclitaxel Fresenius Kabi
    • Poland (PL)
      Paclitaxel Kabi
    • Latvia (LV)
      Paclitaxel Kabi 6 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Paclitaxel Kabi 6 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
    • Hungary (HU)
      PACLITAXEL KABI 6 mg/ml koncentrátum oldatos infúzióhoz
    • Romania (RO)
      Paclitaxel Kabi 6mg/ml concentrat pentru soluţie perfuzabilă
    • Slovakia (SK)
      Paclitaxel Kabi 6mg/ml
    • Slovenia (SI)
    • Czechia (CZ)
    • Ireland (IE)
    • France (FR)
许可日期2009/01/10
最近更新日期2025/09/22
药物ATC编码
    • L01CD01 paclitaxel
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase